Healthcare-associated viral and bacterial infections in dentistry

Journal of Oral Microbiology

Volumn 4, Issue 2012, 2012, Pages

  Laheij, A M G A ^a   Kistler, J O ^b   Belibasakis, G N ^c   Valimaa H ^d,e   de Soet, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bacteria; Cross infection; Cross transmission; Dentistry; Healthcare associated infections; Viruses

Indexed keywords

ALCOHOL; CARBAPENEMASE; DISINFECTANT AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; TUMOR NECROSIS FACTOR INHIBITOR;

ALCOHOLISM; ANTIGEN DETECTION; BACTERIAL INFECTION; BLOOD DONOR; BLOODSTREAM INFECTION; BURN; CHICKENPOX; CHRONIC INFLAMMATION; COLONY FORMING UNIT; CROSS INFECTION; DELTA AGENT HEPATITIS; DENTAL ASSISTANT; DENTAL PRACTICE; DENTAL PROCEDURE; DENTAL UNIT WATERLINE; DENTISTRY; DISEASE TRANSMISSION; ENDOTRACHEAL INTUBATION; ENTEROBACTERIACEAE; EUROPE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EYE INFECTION; FLU LIKE SYNDROME; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; HEALTHCARE ASSOCIATED INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HERPES LABIALIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPETIC STOMATITIS; HERPETIC WHITLOW; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG TUBERCULOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL COLONIZATION; MIXED INFECTION; MUCOSA; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRITION; OCCUPATIONAL EXPOSURE; ORAL BLISTER; ORAL MUCOSAL DISEASE; PROTOZOON; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; REVIEW; RISK ASSESSMENT; SEROPREVALENCE; SKIN; SKIN INFECTION; TREATMENT RESPONSE; TUBERCULOSIS; TUBERCULOSIS CONTROL; URINARY TRACT INFECTION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION; WATER SUPPLY;

EID: 84864826551     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v4i0.17659     Document Type: Review

References (118)

1. Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80: 185-91.
2. Karjala Z, Neal D, Rohrer J. Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008. PLoS One 2011; 6: e19092.
3. Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis 2011; 11: 69.
4. Wheeler CE, Jr. The herpes simplex problem, J Am Acad Dermatol 1988; 18: 163-8.
5. Kameyama T, Sujaku C, Yamamoto S, Hwang CB, Shillitoe EJ. Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol 1988; 17: 478-81.
6. Hanley PJ, Conaway MM, Halstead DC, Rhodes LV, III, Reed J, III. Nosocomial herpes simplex virus infection associated with oral endotracheal intubation. Am J Infect Control 1993; 21: 310-6.
7. Spruance SL. Herpes simplex labialis. In: Sacks SL, Straus SE, Whiteley RJ, Griffiths PD, eds. Clinical management of herpes viruses. Amsterdam: IOS Press; 1995. p. 3-42.
8. Browning WD, Mccarthy JP. A case series: herpes simplex virus as an occupational hazard. J Esthet Restor Dent 2012; 24: 61-6.
9. Rowe NH, Heine CS, Kowalski CJ. Herpetic whitlow: an occupational disease of practicing dentists. J Am Dent Assoc 1982; 105: 471-3.
10. Manzella JP, Mcconville JH, Valenti W, Menegus MA, Swierkosz EM, Arens M. An outbreak of herpes simplex virus type I gingivostomatitis in a dental hygiene practice. JAMA 1984; 252: 2019-22.
11. Wolleswinkel-Van Den Bosch JH, Speets AM, Rumke HC, Gumbs PD, Fortanier SC. The burden of varicella from a parent's perspective and its societal impact in the Netherlands: an Internet survey. BMC Infect Dis 2011; 11: 320.
12. Gnann Jr JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347: 340-6.
13. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48(Suppl 1): S2-7.
14. Langley JM, Hanakowski M. Variation in risk for nosocomial chickenpox after inadvertent exposure. J Hosp Infect 2000; 44: 224-6.
15. Yoshikawa T, Ihira M, Suzuki K, Suga S, Tomitaka A, Ueda H, et al. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol 2001; 63: 64-6.
16. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004; 189: 1009-12.
17. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102: 9-15.
18. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990; 113: 740-6.
19. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian multicenter study. The Italian Study group on occupational risk of HIV infection. Arch Intern Med 1993; 153: 1451-8.
20. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group. N Engl J Med 1997; 337: 1485-90.
21. Shugars DC, Wahl SM. The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 1998; 129: 851-8.
22. Health Protection Agency. Occupational transmission of HIV. Summary of published reports. March 2005 edition. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1194947320156
23. Ciesielski C, Marianos D, Ou CY, Dumbaugh R, Witte J, Berkelman R, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992; 116: 798-805.
24. Astagneau P, Lot F, Bouvet E, Lebascle K, Baffoy N, Aggoune M, et al. Lookback investigation of patients potentially exposed to HIV type 1 after a nurse-to-patient transmission. Am J Infect Control 2002; 30: 242-5.
25. Lot F, Seguier JC, Fegueux S, Astagneau P, Simon P, Aggoune M, et al. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med 1999; 130: 1-6.
26. Bosch X. Second case of doctor-to-patient HIV transmission. Lancet Infect Dis 2003; 3: 261.
27. Mccarthy GM, Sali CS, Bednarsh H, Jorge J, Wangrangsimakul K, Page-Shafer K. Transmission of HIV in the dental clinic and elsewhere. Oral Dis 2002; 8(Suppl 2): 126-35.
28. Health Protection Agency. Occupational transmission of HIV: summary of published reports. March 2005 edition. Data to the end of December 2002. Health Protection Agency Centre for Infections and Collaborators; 2005. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1194947320156
29. Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral infections of humans, fourth ed. New York: Plenum Medical Books Co; 1997. p. 363-418.
30. Hadler SC, Doto IL, Maynard JE, Smith J, Clark B, Mosley J, et al. Occupational risk of hepatitis B infection in hospital workers. Infect Control 1985; 6: 24-31.
31. Cleveland JL, Siew C, Lockwood SA, Gruninger SE, Gooch BF, Shapiro CN. Hepatitis B vaccination and infection among US dentists, 1983-1992. J Am Dent Assoc 1996; 127: 1385-90.
32. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994; 170: 1410-7.
33. Werner BG, Grady GF. Accidental hepatitis-B-surfaceantigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med 1982; 97: 367-9.
34. US Public Health Service. Updated US public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001; 50: 1-52.
35. Lauer JL, Vandrunen NA, Washburn JW, Balfour HH, Jr. Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis 1979; 140: 513-6.
36. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1: 550-1.
37. Perry JL, Pearson RD, Jagger J. Infected health care workers and patient safety: a double standard. Am J Infect Control 2006; 34: 313-9.
38. Redd JT, Baumbach J, Kohn W, Nainan O, Khristova M, Williams I. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis 2007; 195: 1311-4.
39. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-62.
40. Bellentani S, Miglioli L, Masutti F, Saccoccio G, Tiribelli C. Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery. Microbes Infect 2000; 2: 1757-63.
41. Naoumov NV. Hepatitis C virus infection in Eastern Europe. J Hepatol 1999; 31(Suppl 1): 84-7.
42. SievertW, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31(Suppl 2): 61-80.
43. Jagger J, Puro V, De Carli G. Occupational transmission of hepatitis C virus. JAMA 2002; 288: 1469; author reply 1469-71.
44. Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005; 41: 1423-30.
45. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991; 338: 1539-42.
46. Weegink CJ, Sentjens RE, Van Der Heyden JF, Chamuleau RA, Tytgat GN, Beld MG. A physician with a positive hepatitis C virus RNA test after a needlestick injury. Eur J Gastroenterol Hepatol 2003; 15: 1367-9.
47. Berger CM, Leentvaar-Kuijpers A, Van Doornum GJ, Coutinho RA. Accidentele blootstelling aan bloed en risico op transmissie van virusinfecties bij verschillende beroepsgroepen in Amsterdam, 1986-1996. Ned Tijdschr Geneeskd 1998; 142: 2312-4.
48. Lodi G, Porter SR, Teo CG, Scully C. Prevalence of HCV infection in health care workers of a UK dental hospital. Br Dent J 1997; 183: 329-32.
49. Porter S, Scully C, Samaranayake L. Viral hepatitis. Current concepts for dental practice. Oral Surg Oral Med Oral Pathol 1994; 78: 682-95.
50. Lawn SD, Zumla AI. Tuberculosis. Lancet 2011; 378: 57-72.
51. Abubakar I, Lipman M, Anderson C, Davies P, Zumla A. Tuberculosis in the UK - time to regain control. BMJ 2011; doi: 10.1136/bmj.d4281.
52. Carvalho AC, Migliori GB, Cirillo DM. Tuberculosis in Europe: a problem of drug resistance or much more? Expert Rev Respir Med 2010; 4: 189-200.
53. Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001; 345: 189-200.
54. Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev 2012; 36: 514-32.
55. Barry CE, III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7: 845-55.
56. Cleveland JL, Gooch BF, Bolyard EA, Simone PM, Mullan RJ, Marianos DW. TB infection control recommendations from the CDC, 1994: considerations for dentistry. United States Centers for Disease Control and Prevention. J Am Dent Assoc 1995; 126: 593-9.
57. Cleveland JL, Robison VA, Panlilio AL. Tuberculosis epidemiology, diagnosis and infection control recommendations for dental settings: an update on the Centers for disease control and prevention guidelines. JAm Dent Assoc 2009; 140: 1092-9.
58. Smith WH, Davies D, Mason KD, Onions JP. Intraoral and pulmonary tuberculosis following dental treatment. Lancet 1982; 1: 842-4.
59. Cleveland JL, Kent J, Gooch BF, Valway SE, Marianos DW, Butler WR, et al. Multidrug-resistant Mycobacterium tuberculosis in an HIV dental clinic. Infect Control Hosp Epidemiol 1995; 16: 7-11.
60. Harlow RF, Rutkauskas JS. Tuberculosis risk in the hospital dental practice. Spec Care Dentist 1995; 15: 50-5.
61. Cadmus SI, Okoje VN, Taiwo BO, Van Soolingen D. Exposure of dentists to Mycobacterium tuberculosis, Ibadan, Nigeria. Emerg Infect Dis 2010; 16: 1479-81.
62. Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 2011; 139: 909-19.
63. Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol 2011; 12: 157-69.
64. Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health 2009; 2: 101-11.
65. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect (Larchmt) 2009; 10: 389-97.
66. Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci 2007; 84: 273-8.
67. Van Delden C. Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents 2007; 30(Suppl 1): S71-5.
68. Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res 2010; 10: 441-51.
69. Barbeau J, Tanguay R, Faucher E, Avezard C, Trudel L, Cote L, et al. Multiparametric analysis of waterline contamination in dental units. Appl Environ Microbiol 1996; 62: 3954-9.
70. Barben J, Kuehni CE, Schmid J. Water quality in dental chair units. A random sample in the canton of St. Gallen. Schweiz Monatsschr Zahnmed 2009; 119: 976-85.
71. Jensen ET, Giwercman B, Ojeniyi B, Bangsborg JM, Hansen A, Koch C, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect 1997; 36: 117-22.
72. Martin MV. The significance of the bacterial contamination of dental unit water systems. Br Dent J 1987; 163: 152-4.
73. Scannapieco FA, Ho AW, Ditolla M, Chen C, Dentino AR. Exposure to the dental environment and prevalence of respiratory illness in dental student populations. J Can Dent Assoc 2004; 70: 170-4.
74. Pankhurst CL, Coulter W, Philpott-Howard JN, Surman-Lee S, Warburton F, Challacombe S. Evaluation of the potential risk of occupational asthma in dentists exposed to contaminated dental unit waterlines. Prim Dent Care 2005; 12: 53-9.
75. Putnins EE, Di Giovanni D, Bhullar AS. Dental unit waterline contamination and its possible implications during periodontal surgery. J Periodontol 2001; 72: 393-400.
76. Newton HJ, Ang DK, Van Driel IR, Hartland EL. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev 2010; 23: 274-98.
77. Gomez-Valero L, Rusniok C, Buchrieser C. Legionella pneumophila: population genetics, phylogeny and genomics. Infect Genet Evol 2009; 9: 727-39.
78. Wadowsky RM, Wolford R, Mcnamara AM, Yee RB. Effect of temperature, pH, and oxygen level on the multiplication of naturally occurring Legionella pneumophila in potable water. Appl Environ Microbiol 1985; 49: 1197-205.
79. Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis 2002; 2: 368-73.
80. Pankhurst CL, Coulter WA. Do contaminated dental unit waterlines pose a risk of infection? J Dent 2007; 35: 712-20.
81. Atlas RM, Williams JF, Huntington MK. Legionella contamination of dental-unit waters. Appl Environ Microbiol 1995; 61: 1208-13.
82. Challacombe SJ, Fernandes LL. Detecting Legionella pneumophila in water systems: a comparison of various dental units. J Am Dent Assoc 1995; 126: 603-8.
83. Walker JT, Bradshaw DJ, Bennett AM, Fulford MR, Martin MV, Marsh PD. Microbial biofilm formation and contamination of dental-unit water systems in general dental practice. Appl Environ Microbiol 2000; 66: 3363-7.
84. Veronesi L, Capobianco E, Affanni P, Pizzi S, Vitali P, Tanzi ML. Legionella contamination in the water system of hospital dental settings. Acta Biomed 2007; 78: 117-22.
85. Pankhurst CL, Coulter W, Philpott-Howard JJ, Harrison T, Warburton F, Platt S, et al. Prevalence of legionella waterline contamination and Legionella pneumophila antibodies in general dental practitioners in London and rural Northern Ireland, Br Dent J 2003; 195: 591-4; discussion 581.
86. Pankhurst CL. Risk assessment of dental unit waterline contamination. Prim Dent Care 2003; 10: 5-10.
87. Ricci ML, Fontana S, Pinci F, Fiumana E, Pedna MF, Farolfi P, et al. Pneumonia associated with a dental unit waterline. Lancet 2012; 379: 684.
88. Fotos PG, Westfall HN, Snyder IS, Miller RW, Mutchler BM. Prevalence of Legionella-specific IgG and IgM antibody in a dental clinic population. J Dent Res 1985; 64: 1382-5.
89. Reinthaler FF, Mascher F, Stunzner D. Serological examinations for antibodies against Legionella species in dental personnel. J Dent Res 1988; 67: 942-3.
90. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/1111-SUR-AMR-data.pdf.pdf
91. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobialresistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136: 834-44.
92. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, the CNSE Working Group. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010; 15(46): pii=19711. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19711
93. Wieler LH, Ewers C, Guenther S, Walther B, Lubke-Becker A. Methicillin-resistant staphylococci (MRS) and extendedspectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol 2011; 301: 635-41.
94. Smith AJ, Robertson D, Tang MK, Jackson MS, Mackenzie D, Bagg J. Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data. Br Dent J 2003; 195: 701-3; discussion 694.
95. O'Leary E, Lockhart DE, Smith A. Coming to a practice near you? Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA). Dent Update 2011; 38: 254-6, 259-60.
96. Parton M, Beasley NJ, Harvey G, Houghton D, Jones AS. Four cases of aggressive MRSA wound infection following head and neck surgery. J Laryngol Otol 1997; 111: 874-6.
97. Mitchell TE, Pickles JM. Four cases of aggressive MRSA wound infection following head and neck surgery. J Laryngol Otol 1998; 112: 422.
98. Supriya M, Shakeel M, Santangeli L, Ah-See KW. Controlling MRSA in head and neck cancer patients: what works? Otolaryngol Head Neck Surg 2009; 140: 224-7.
99. Smith AJ, Jackson MS, Bagg J. The ecology of Staphylococcus species in the oral cavity. J Med Microbiol 2001; 50: 940-6.
100. Kock R, Becker K, Cookson B, Van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010; 15: 19688.
101. Petti S, Polimeni A. Risk of methicillin-resistant staphylococcus aureus transmission in the dental healthcare setting: a narrative review. Infect Control Hosp Epidemiol 2011; 32: 1109-15.
102. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008; 8: 289-301.
103. Reddy Y. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) nazal colonization among dental professionals (MPH thesis). Ann Arbor, MI: ProQuest; 2010.
104. Gorwitz RJ, Kruszon-Moran D, Mcallister SK, Mcquillan G, Mcdougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197: 1226-34.
105. Roberts MC, Soge OO, Horst JA, Ly KA, Milgrom P. Methicillin-resistant Staphylococcus aureus from dental school clinic surfaces and students. Am J Infect Control 2011; 39: 628-32.
106. Martin MV, Hardy P. Two cases of oral infection by methicillin-resistant Staphylococcus aureus. Br Dent J 1991; 170: 63-4.
107. Kurita H, Kurashina K, Honda T. Nosocomial transmission of methicillin-resistant Staphylococcus aureus via the surfaces of the dental operatory, Br Dent J 2006; 201: 297-300; discussion 291.
108. Motta RH, Groppo FC, Bergamaschi C, de C, Ramacciato JC, Baglie S, De Mattos-Filho TR. Isolation and antimicrobial resistance of staphylococcus aureus isolates in a dental clinic environment. Infect Control Hosp Epidemiol 2007; 28: 185-90.
109. Westergard EJ, Romito LM, Kowolik MJ, Palenik CJ. Controlling bacterial contamination of dental impression guns. J Am Dent Assoc 2011; 142: 1269-74.
110. Egusa H, Watamoto T, Abe K, Kobayashi M, Kaneda Y, Ashida S, et al. An analysis of the persistent presence of opportunistic pathogens on patient-derived dental impressions and gypsum casts. Int J Prosthodont 2008; 21: 62-8.
111. Grover SS, Sharma M, Pasha ST, Singh G, Lal S. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi. J Commun Dis 2004; 36: 17-26.
112. Mobbs KJ, Van Saene HK, Sunderland D, Davies PD. Oropharyngeal Gram-negative bacillary carriage: a survey of 120 healthy individuals. Chest 1999; 115: 1570-5.
113. Mehra P, Murad H. Maxillary sinus disease of odontogenic origin. Otolaryngol Clin North Am 2004; 37: 347-64.
114. March A, Aschbacher R, Dhanji H, Livermore DM, Bottcher A, Sleghel F, et al. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 2010; 16: 934-44.
115. Murk JL, Heddema ER, Hess DL, Bogaards JA, Vandenbroucke-Grauls CM, Debets-Ossenkopp YJ. Enrichment broth improved detection of extended-spectrum-betalactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units. J Clin Microbiol 2009; 47: 1885-7.
116. Roshan M, Ikram A, Mirza IA, Malik N, Abbasi SA, Alizai SA. Susceptibility pattern of extended spectrum ß-lactamase producing isolates in various clinical specimens. J Coll Physicians Surg Pak 2011; 21: 342-6.
117. Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ, et al. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospitalbased health care providers still at risk? Clin Infect Dis 2003; 37: 1006-13.
118. Molinari JA. Infection control: its evolution to the current standard precautions. J Am Dent Assoc 2003; 134: 569-74; quiz 631-2.